Tag: Sorrento Therapeutics

Finance

Biotech Gainers: Fate Therapeutics Inc (NASDAQ:FATE), ZIOPHARM Oncology (NASDAQ:ZIOP), Uniqure NV (NASDAQ:QURE), Sorrento Therapeutics (NASDAQ:SRNE)

Fate Therapeutics Inc (NASDAQ:FATE) recently issued a statement that it has enrolled it first patient for the second phase of this study. The primary aim of the PUMA study is to assess the efficacy and safety of PROHEMA in a randomized, controlled environment for patients that are under treatment for hematopoietic stem cell or HSC transplantation for hematologic malignancies. Fate Therapeutics Inc (NASDAQ:FATE) stock performance … Continue reading Biotech Gainers: Fate Therapeutics Inc (NASDAQ:FATE), ZIOPHARM Oncology (NASDAQ:ZIOP), Uniqure NV (NASDAQ:QURE), Sorrento Therapeutics (NASDAQ:SRNE)

Colin Pettis
Finance

Traders Are Watching : Energous Corporation (NASDAQ:WATT), Nike, Inc. (NYSE:NKE), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Sotherly Hotels Inc. (NASDAQ:SOHO), PPL Corporation (NYSE:PPL)

Energous Corporation (NASDAQ:WATT), the developer of WattUp™, a disruptive wire-free charging technology for electronic devices that provides power at a distance with complete mobility under full software control, on AUG 22 announced it has issued Inducement Awards and Performance Awards of restricted stock units to our Senior Vice President of Engineering pursuant to his offer letter. Energous Corporation (NASDAQ:WATT) belongs to Consumer Goods sector. Its … Continue reading Traders Are Watching : Energous Corporation (NASDAQ:WATT), Nike, Inc. (NYSE:NKE), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Sotherly Hotels Inc. (NASDAQ:SOHO), PPL Corporation (NYSE:PPL)

Chris Lewis